Vivace Therapeutics’ $30 Million Series C financing

Wilson Sonsini Goodrich & Rosati advised Vivace Therapeutics, Inc. on the deal. Vivace Therapeutics, Inc., a small molecule drug discovery and development company focused on targeting…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Ambrogio Visconti

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here